Exhibit 4.4
CLINICAL RESEARCH CONSULTING AGREEMENT
(renewed)
THIS CLITICAL RESEARCH AGREEMENT is made effective this 1
st day of 2005 by and;
BETWEEN:
WOO-KYUNG SEO, 403-909, 4th Block, Tanhyun Village,
Tanhyun-Dong, Ilsan-Ku, Koyang-City, Kyeonggi-Do, Korea
(hereinafter referred to as “CONSULTANT”)
AND:
MERIDIAN CO., LTD., of 9Fl., Seoil Bldg. 222, Jamsilbon-dong,
Songpa-gu Seoul, Republic of Korea (hereinafter referred to as
“MERIDIAN”)
WHEREAS:
A. MERIDIAN is engaged in the research,
development, manufacturing and sales of medical devices mainly for
the Oriental and Natural/Alternative Medicine;
B. CONSULTANT is a medical professional
providing clinical research services in the North American
regulatory standard; and
C. MERIDIAN considers it to be in its
best interest to engage CONSULTANT to receive clinical research
consulting services for its products in North America on the terms
and subject to the conditions hereinafter set forth.
NOW THEREFORE THIS AGREEMENT WITNESS THAT the parties
mutually agree as follows:
A. ENGAGEMENT
| 1.3 |
Subject to the terms and conditions hereof,
MERIDIAN hereby engages CONSULTANT to receive the clinical research
services set out in Section 2 hereof (the
“Services”).
|
| |
| 1.4 |
CONSULTANT’s obligation to perform the
Services shall commence following the completion of the list of the
Services, and will continue from the Effective Date until
terminated in accordance with Article 4 hereof (the
“Term”).
|
B. SERVICES
| 2.1 |
Conduct the medical research on every products
of MERIDIAN, which is acceptable in the US medical industry.
|
| |
| 2.2 |
Prepare the appropriate research results for
the Meridian Products to meet the FDA standard.
|
| |
| 2.3 |
Examine the products for FDA regulations
(510(k)), Pre-market Approval, Investigation Device
Exemption.
|
C. CONSIDERATION
|
